Allogeneic Marrow Transplantation in Patients With Severe Systemic Sclerosis: Resolution of Dermal Fibrosis

OBJECTIVE: To evaluate the safety and efficacy of allogeneic hematopoietic cell transplantation (HCT) after myeloablative conditioning in patients with severe systemic sclerosis (SSc). METHODS: Eligibility criteria for the study included SSc patients with features indicative of a poor prognosis. The...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Nash, Richard A., McSweeney, Peter A., Nelson, J. Lee, Wener, Mark, Georges, George E., Langston, Amelia A., Shulman, Howard, Sullivan, Keith M., Lee, Julie, Henstorf, Gretchen, Storb, Rainer, Furst, Daniel E.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2006
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2956579/
https://ncbi.nlm.nih.gov/pubmed/16732546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.21908
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi